With Novis' forward-thinking program, differentiated customer service was also a goal. With the new system in place, customers can also more easily access information about their drugs – something the competition cannot claim. Novis' system is expected to provide a Web-based portal to enable customers to view and manage their drug supply and related pedigree information through their entire process. This eliminates the necessity of customers procuring their own extensive product security systems. Additional value-add is provided by the ability to develop event management functionality that can alert customers based on predefined business rules. For example, alerts can be sent prior to a drug reaching its expiration date or if a drug, needing refrigeration, is not scanned into its proper storage location.
With an official launch of its NOVIS RxID program slated for mid-2009, Novis will become one of the leaders in demonstrating that protecting patient safety can be good business if you keep your eye on your key strategic imperatives, be they product integrity, operational efficiency, customer service, or other.
As recent incidents making headlines and historical issues make clear, threats to pharmaceutical product security aren't going away. Indeed, the trend is an increasing one and current economic conditions will only serve to stimulate this trend. The underlying regulatory environment, both in the United States and in other regions such as the European Union, does not appear to be converging on any one formula. In addition, no single security element appears to provide the systemic security protections needed at reasonable economic cost. The question for many businesses in this uncertain environment is whether to sit back and wait for clarity or move forward and drive the bus. Early evidence suggests that those firms that seize the opportunity by starting now with detailed strategic analysis and business planning which incorporates all facets of the business will be best positioned to not only survive but thrive. The question is where your business lies on this spectrum of readiness?
About the Author: Brian Daleiden is director of product and corporate marketing at SupplyScape Corporation, a software and consulting services company dedicated to protecting the value and safety of the global life sciences supply chain through product traceability and collaboration solutions. More information available at www.supplyscape.com.